Companion diagnostics market foresees 15.2% CAGR until 2028 | Healthcare Asia Magazine
Photo from National Cancer Institute on Unsplash

Companion diagnostics market foresees 15.2% CAGR until 2028

The global market is estimated to reach $15.4b within the forecast period.

The global companion diagnostics market is expected to reach $15.4b by 2028 at a compound annual growth rate (CAGR) of 15.2%, according to BCC Research.

The report revealed that the market was driven by factors such as the rising incidence of cancer, an increasing need for personalised medicine, and advances in next-generation sequencing (NGS) technologies.

ALSO READ: Long-term care market projects 3.33% CAGR until 2027

Moreover, an expanded application of treatments and tools in non-oncology areas has also driven the market’s growth.

Tests or therapies originally specified for cancer may now be applied to conditions including brain diseases, heart problems, infections, and other illnesses. 


Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!